pI: 6.2554 |
Length (AA): 211 |
MW (Da): 24789 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 211 | 1okt (A) | 1 | 211 | 99.99 | 0 | 1 | 2.32 | -2.52 |
3 | 207 | 4zxg (A) | 3 | 207 | 99.99 | 0 | 1 | 2.25566 | -2.01 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 24 hs, intra-erythrocytic - 48 hs, merozoite, sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite, Ring. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, gametocyte, Oocyst. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 0 hs. | Otto TD |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Female Gametocyte, Male Gametocyte. | Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | Sporozoite. | Zanghi G |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_128539)
Species | Accession | Gene Product |
---|---|---|
Caenorhabditis elegans | CELE_T28A11.11 | Protein GST-23 |
Caenorhabditis elegans | CELE_F37B1.5 | Protein GST-16 |
Dictyostelium discoideum | DDB_G0280317 | hypothetical protein |
Dictyostelium discoideum | DDB_G0283575 | hypothetical protein |
Dictyostelium discoideum | DDB_G0274081 | hypothetical protein |
Dictyostelium discoideum | DDB_G0268138 | hypothetical protein |
Dictyostelium discoideum | DDB_G0272632 | hypothetical protein |
Echinococcus granulosus | EgrG_000535300 | glutathione s transferase mu |
Echinococcus granulosus | EgrG_000535200 | glutathione S transferase |
Echinococcus granulosus | EgrG_000538900 | glutathione S transferase |
Echinococcus granulosus | EgrG_000538700 | glutathione S transferase |
Echinococcus multilocularis | EmuJ_000537600 | glutathione S transferase |
Echinococcus multilocularis | EmuJ_000538300 | glutathione S-transferase |
Echinococcus multilocularis | EmuJ_000535200 | glutathione S transferase |
Echinococcus multilocularis | EmuJ_000535300 | glutathione s transferase mu |
Echinococcus multilocularis | EmuJ_000538700 | glutathione S transferase |
Echinococcus multilocularis | EmuJ_000538000 | glutathione S transferase |
Echinococcus multilocularis | EmuJ_000538900 | glutathione S transferase |
Echinococcus multilocularis | EmuJ_000005400 | glutathione S transferase |
Homo sapiens | ENSG00000134202 | glutathione S-transferase mu 3 (brain) |
Homo sapiens | ENSG00000213366 | glutathione S-transferase mu 2 (muscle) |
Homo sapiens | ENSG00000168765 | glutathione S-transferase mu 4 |
Mus musculus | ENSMUSG00000027890 | glutathione S-transferase, mu 4 |
Mus musculus | ENSMUSG00000004035 | glutathione S-transferase, mu 7 |
Mus musculus | ENSMUSG00000004038 | glutathione S-transferase, mu 3 |
Mus musculus | ENSMUSG00000004032 | glutathione S-transferase, mu 5 |
Plasmodium falciparum | PF3D7_1419300 | glutathione S-transferase |
Schistosoma japonicum | Sjp_0038300 | ko:K00799 glutathione S-transferase [EC2.5.1.18], putative |
Schistosoma mansoni | Smp_102070 | GST class-mu |
Schistosoma mansoni | Smp_163610 | glutathione-S-transferase |
Schmidtea mediterranea | mk4.001107.01 | |
Schmidtea mediterranea | mk4.000889.01 | |
Schmidtea mediterranea | mk4.007945.00 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
catalytic activity (GO:0003824) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Plasmodium falciparum | 87593 261984 536707 | |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 12108547 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
Compound | Source | Reference |
---|---|---|
ChEMBL23 | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References |
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | glutathione S-transferase mu 2 (muscle) | Compounds | References |
81 literature references were collected for this gene.